Health Reference LibraryDoes ashwagandha work for stress and sleep, and what dose did the trials use?
This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Summary
Ashwagandha has genuinely reasonable randomised evidence for a herb. One double blind trial found 240 mg a day of concentrated root extract for 60 days reduced anxiety scores and morning cortisol; another found 250 and 600 mg a day cut perceived stress over 8 weeks; and a meta-analysis found improved sleep, clearest at 600 mg a day for 8 weeks or more in people with diagnosed sleeplessness. Effects build over weeks. Trials used root extracts standardised to withanolides at 240 to 600 mg a day. Two honest cautions: rare liver injury case reports, arguing for trial range doses over defined periods, and thyroid activity, since ashwagandha can nudge thyroid hormones upward. Each capsule provides 450 mg standardised root extract.
How it works
Withanolides appear to damp hypothalamic pituitary adrenal axis overactivity, the system behind cortisol output, which fits the repeated trial finding of lowered morning cortisol alongside lowered stress scores. GABA receptor modulation is the proposed route for the calming and sleep effects. Ashwagandha also shows mild thyroid stimulating activity in small studies, raising T4 in some participants, a genuine pharmacological action rather than folklore, which is why thyroid status appears under the cautions.
Effective dose
The trial range is 240 to 600 mg a day of concentrated, standardised root extract. The anxiety and cortisol trial used 240 mg once daily for 60 days; the stress trial used 250 and 600 mg a day for 8 weeks with the larger dose performing better on cortisol; the sleep meta-analysis found the clearest effect at 600 mg a day for at least 8 weeks. At 450 mg of concentrated extract per capsule, one capsule sits inside the trial range and two reach its top. There is no UK reference intake; ashwagandha is a herb, not a nutrient.
Forms compared
Root extract is the researched material; the trials used concentrated root extracts standardised to withanolide content, and the two best known trial preparations were 10:1 class concentrates. Whole root powder is far weaker per gram and behind none of the modern trials. Standardisation percentages are measured differently between products, by gravimetric or chromatographic methods, so percentage labels are not directly comparable across brands; what matters is a concentrated, standardised root extract at trial range daily amounts. The stocked capsule provides 450 mg of 10:1 root extract standardised to 1.5 percent withanolides.
Timing
The stress trials dosed morning or twice daily; the sleep evidence dosed in the evening or split. A sensible default: one capsule with the evening meal for sleep focused use, or split morning and evening for general stress, since the mechanism is cumulative rather than sedative on the night. The meta-analysis signal was clearest at 8 weeks and beyond, so ashwagandha is a weeks to months commitment, and a two to three month block followed by a deliberate break is a better pattern than indefinite use.
Safety profile
Trials up to 12 weeks report good tolerability, with drowsiness and digestive upset the common complaints. Two cautions deserve plain words. Liver: case reports and registry entries link ashwagandha products to rare liver injury, typically resolving after stopping; standardised extracts at trial doses for defined periods are the sensible response, with immediate stopping if unusual fatigue, dark urine or yellowing appears. Thyroid: the hormone raising nudge is unwanted in overactive thyroid and unpredictable alongside thyroid hormone therapy. Long term safety beyond a few months is simply not established, another argument for blocks with breaks.
Special populations
Pregnancy is a hard no: ashwagandha has traditional use as an abortifacient at high doses and no safety data at any dose, so avoid entirely, and the same caution applies to breastfeeding. Anyone with an overactive thyroid or on levothyroxine needs clinical involvement because of the hormone raising activity. Autoimmune conditions and immunosuppressive therapy sit in the avoid category given the immune stimulating activity. People with liver conditions should not take ashwagandha without clinical advice. Nightshade sensitivity occasionally extends to ashwagandha, a nightshade family plant.
Interactions
Four conversations matter. Thyroid: ashwagandha can raise thyroid hormone levels, so anyone on levothyroxine or with an overactive thyroid should involve their prescriber, since the effect can add to existing hormone. Sedatives: the calming action can add to prescribed sedatives and sleep drugs. Immunosuppressants: ashwagandha has immune stimulating activity in laboratory work, so transplant patients and anyone on immunosuppressive therapy should avoid it. Blood pressure and blood sugar: mild lowering effects can add to prescribed drugs for either, worth watching readings when starting.
Guideline positions
No UK reference intake or NHS position exists for ashwagandha. The anchor evidence is three publications: a randomised double blind trial of 240 mg a day for 60 days on anxiety and cortisol, a randomised double blind trial of 250 and 600 mg a day for 8 weeks on perceived stress, and a systematic review and meta-analysis of randomised trials on sleep finding the clearest benefit at 600 mg a day for 8 weeks or more. UK and international pharmacovigilance systems carry the rare liver injury case reports reflected in the safety section.
Practical framework
Ashwagandha is most rational for someone under sustained stress with poor sleep who wants a researched herbal option and will run it properly: one to two capsules a day for an 8 to 12 week block, judged against something concrete, a sleep diary, morning mood, or a wearable's night data, then a deliberate break. Anyone on thyroid, sedative, immunosuppressive, blood pressure or blood sugar drugs needs the prescriber conversation first. If nothing has moved by 12 weeks, stop; the evidence does not support indefinite background use. The stocked option is a 450 mg standardised root extract capsule at nutritailor.co.uk/products/ashwagandha.
Common misconceptions
Ashwagandha is not a sedative that works the first night; the trials measured change over weeks, and the sleep benefit was clearest after 8 weeks in people with genuine sleeplessness. It is not risk free because it is ancient; the liver case reports and thyroid activity are modern, documented pharmacology. Higher withanolide percentages on labels do not straightforwardly mean stronger products, because standardisation methods differ. And ashwagandha does not lower cortisol into unhealthiness; the trials show normalisation of elevated levels, not suppression below normal.
Sources
- Lopresti AL, Smith SJ, Malvi H, Kodgule R 2019. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). PMID: 31517876
- Salve J, Pate S, Debnath K, Langade D 2019. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. PMID: 32021735
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R 2021. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS One. PMID: 34559859